[2-[3-chloro-5-(trifluoromethyl)phenyl]-4-fluorophenyl]-[(1-methylpyrrolidin-3-yl)methyl]carbamic acid
C20H19ClF4N2O2 — CID 121411390
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-[3-chloro-5-(trifluoromethyl)phenyl]-4-fluorophenyl]-[(1-methylpyrrolidin-3-yl)methyl]carbamic acid
[2-[3-chloro-5-(trifluoromethyl)phenyl]-4-fluorophenyl]-[(1-methylpyrrolidin-3-yl)methyl]carbamic acid (PubChem CID 121411390) has the molecular formula C20H19ClF4N2O2 and a molecular weight of 430.83 g/mol. Its IUPAC name is [2-[3-chloro-5-(trifluoromethyl)phenyl]-4-fluorophenyl]-[(1-methylpyrrolidin-3-yl)methyl]carbamic acid.
Molecular Properties
| Compound Name | [2-[3-chloro-5-(trifluoromethyl)phenyl]-4-fluorophenyl]-[(1-methylpyrrolidin-3-yl)methyl]carbamic acid |
|---|---|
| PubChem CID | 121411390 |
| Molecular Formula | C20H19ClF4N2O2 |
| Molecular Weight | 430.83 g/mol |
| Exact Mass | 430.11 |
| IUPAC Name | [2-[3-chloro-5-(trifluoromethyl)phenyl]-4-fluorophenyl]-[(1-methylpyrrolidin-3-yl)methyl]carbamic acid |
| SMILES | CN1CCC(CN(C(=O)O)c2ccc(F)cc2-c2cc(Cl)cc(C(F)(F)F)c2)C1 |
| InChI | InChI=1S/C20H19ClF4N2O2/c1-26-5-4-12(10-26)11-27(19(28)29)18-3-2-16(22)9-17(18)13-6-14(20(23,24)25)8-15(21)7-13/h2-3,6-9,12H,4-5,10-11H2,1H3,(H,28,29) |
| InChIKey | UVGLLJUDJWYBDQ-UHFFFAOYSA-N |
| XLogP | 5.60 |
| TPSA | 43.78 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 430.83 |
| LogP ≤ 5 | 5.60 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121411390 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.